Abstract:Background Acute lung injury (ALI) and its most severe form acute respiratory distress syndrome (ARDS) have been the leading cause of morbidity and mortality in intensive care units (ICU). Currently, there is no effective pharmacological treatment for acute lung injury. Curcumin, extracted from turmeric, exhibits broad anti-inflammatory properties through down-regulating inflammatory cytokines. However, the instability of curcumin limits its clinical application. Methods A series of new curcumin analogs were synthesized and screened for their inhibitory effects on the production of TNF-α and IL-6 in mouse peritoneal macrophages by ELISA. The evaluation of stability and mechanism of active compounds was determined using UV-assay and Western Blot, respectively. In vivo , SD rats were pretreatment with c26 for seven days and then intratracheally injected with LPS to induce ALI. Pulmonary edema, protein concentration in BALF, injury of lung tissue, inflammatory cytokines in serum and BALF, inflammatory cell infiltration, inflammatory cytokines mRNA expression, and MAPKs phosphorylation were analyzed. We also measured the inflammatory gene expression in human pulmonary epithelial cells. Results In the study, we synthesized 30 curcumin analogs. The bioscreeening assay showed that most compounds inhibited LPS-induced production of TNF-α and IL-6. The active compounds, a17 , a18 , c9 and c26 , exhibited their anti-inflammatory activity in a dose-dependent manner and exhibited greater stability than curcumin in vitro . Furthermore, the active compound c26 dose-dependently inhibited ERK phosphorylation. In vivo , LPS significantly increased protein concentration and number of inflammatory cells in BALF, pulmonary edema, pathological changes of lung tissue, inflammatory cytokines in serum and BALF, macrophage infiltration, inflammatory gene expression, and MAPKs phosphorylation. However, pretreatment with c26 attenuated the LPS induced increase through ERK pathway in vivo. Meanwhile, compound c26 reduced the LPS-induced inflammatory gene expression in human pulmonary epithelial cells. Conclusions These results suggest that the novel curcumin analog c26 has remarkable protective effects on LPS-induced ALI in rat. These effects may be related to its ability to suppress production of inflammatory cytokines through ERK pathway. Compound c26 , with improved chemical stability and bioactivity, may have the potential to be further developed into an anti-inflammatory candidate for the prevention and treatment of ALI.

Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS)

Compound Edaravone Alleviates Lipopolysaccharide (Lps)-Induced Acute Lung Injury in Mice.

Dimethyl malonate protects the lung in a murine model of acute respiratory distress syndrome

Evaluation of interleukin-1 and interleukin-6 receptor antagonists in a murine model of acute lung injury

Treatment with natural AhR ligand leads to amelioration of LPS-induced acute lung injury by decreasing microRNA 29b-2-5p expression targeting increased IL-22 production

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury

Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Alveolar Epithelial Cell Proliferation and Lung Regeneration in the Lipopolysaccharide-Induced Acute Lung Injury Mouse Model

Diterpene Coronarin Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Both In Vivo and In Vitro Models

Effect of Allicin on Mice with Acute Lung Injury Induced by Lipopolysaccharide

Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway

Novel O-benzylcinnamic Acid Derivative L26 Treats Acute Lung Injury in Mice by MD-2.

Plant-derived natural compounds for the treatment of acute lung injury: A systematic review of their anti-inflammatory effects in animal models

Therapeutic Inhibition of CXC Chemokine Receptor 2 by SB225002 Attenuates LPS-induced Acute Lung Injury in Mice

Discovery of the Specific Inhibitory Effect of Thiamphenicol on LPS-induced Acute Lung Injury (ALI) in Mice Through Virtual Screening and Biological Evaluation

Evidence that a Novel Chalcone Derivative, Compound 27, Acts on the Epithelium Via the PI3K/AKT/Nrf2-Keap1 Signaling Pathway, to Mitigate LPS-Induced Acute Lung Injury in Mice

Ph-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury

Inhibition of Cathepsin L Ameliorates Inflammation Through the A20/NF-κB Pathway in Endotoxin-Induced Acute Lung Injury

Alleviation of Severe Inflammatory Responses in LPS-exposed Mice by Schisantherin A

Early and late pulmonary effects of nebulized LPS in mice: An acute lung injury model

Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology

Mechanism of MCP-1 in Acute Lung Injury and Advanced Therapy by Drug-Loaded Dextrin Nanoparticle